Answers are grounded in this paper and cite their sources.
Pharmacologic inhibition of the inositol pyrophosphate pathway has strong therapeutic potential in obesity, T2D, and other metabolic diseases.
No takes yet. Share an insight, caveat, or question.
Ghoshal et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: